Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07633639 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity

Name: GLP-1 Therapy After Bariatric Surgery in Chinese Patients With Obesity — clinical trial record (NCT07633639)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhaseNot applicable

SponsorChina-Japan Friendship Hospital

Started2026-05-01

View on ClinicalTrials.gov ↗

China-Japan Friendship Hospital

97 trials monitored

See 2 trials at risk

Obesity

3,523 trials monitored

See 133 trials at risk

Obese patients exhibit considerable heterogeneity and complex comorbidities, making long-term effective management challenging with monotherapy. While bariatric surgery remains the most effective weight-loss intervention, postoperative weight regain and metabolic deterioration remain significant concerns. glucagon-like peptide-1 receptor agonists (GLP-1RA) offer distinct advantages for weight loss and metabolic control, and their combination with surgery may produce synergistic effects. This study investigates the efficacy and safety of bariatric surgery combined with adjuvant GLP-1 receptor agonist therapy for Chinese patients with obesity.

Trial Details

NCT Number	NCT07633639
Lead Sponsor	China-Japan Friendship Hospital
Conditions	Obesity
Enrollment	200 participants
Start Date	2026-05-01
Primary Completion	2028-05-01 (estimated)
Study Completion	2028-05-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-08